Milad Ashrafizadeh

Tuzla, 34956, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 269 publications

Corrigendum to "STAT3-driven EMT in cancer metastasis and chemoresistance: A review" [Int. J. Biol. Macromol. 357 (2026): 151403].

Corrigendum to "STAT3-driven EMT in cancer metastasis and chemoresistance: A review" [Int. J. Biol. Macromol. 357 (2026): 151403].

Journal: International journal of biological macromolecules

Published: June 15, 2026

Retraction notice to "Gene regulation by antisense transcription: A focus on neurological and cancer diseases" [Biomedicine & Pharmacotherapy 145 (2022) 112265].

Retraction notice to "Gene regulation by antisense transcription: A focus on neurological and cancer diseases" [Biomedicine & Pharmacotherapy 145 (2022) 112265].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 10, 2026

Corrigendum to "Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling" [Biomed. Pharmacother. 150 (2022) 112963].

Corrigendum to "Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling" [Biomed. Pharmacother. 150 (2022) 112963].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 12, 2026

Editorial Expression of Concern: Wnt/β-catenin-driven EMT regulation in human cancers.

Editorial Expression of Concern: Wnt/β-catenin-driven EMT regulation in human cancers.

Journal: Cellular and molecular life sciences : CMLS

Published: April 10, 2026

Microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunction.

Microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunction.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 06, 2026

Corrigendum to "Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL" [Mater. Today Bio (35) 102267].

Corrigendum to "Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL" [Mater. Today Bio (35) 102267].

Journal: Materials today. Bio

Published: April 02, 2026

Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824].

Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 20, 2026

Cytoskeletal remodeling promotes tunneling nanotube formation and drives cardiac resident cell mitochondrial transfer in sepsis.

Cytoskeletal remodeling promotes tunneling nanotube formation and drives cardiac resident cell mitochondrial transfer in sepsis.

Journal: Science advances

Published: March 11, 2026

Retraction notice to "AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation" [Biomedicine & Pharmacotherapy 146 (2022) 112563].

Retraction notice to "AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation" [Biomedicine & Pharmacotherapy 146 (2022) 112563].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 07, 2026

c-Myc as a vulnerable target in cancer drug resistance.

c-Myc as a vulnerable target in cancer drug resistance.

Journal: Gene

Published: February 25, 2026

TRIM27-Cas9-loaded EVs suppress HCC proliferation and enhance responsiveness to anti-PD-1 therapy by promoting ACSL4-mediated ferroptosis.

TRIM27-Cas9-loaded EVs suppress HCC proliferation and enhance responsiveness to anti-PD-1 therapy by promoting ACSL4-mediated ferroptosis.

Journal: Cell death and differentiation

Published: February 14, 2026

From symbiosis to immunity: the evolutionary revival of mitochondrial defense programs in inflammatory diseases.

From symbiosis to immunity: the evolutionary revival of mitochondrial defense programs in inflammatory diseases.

Journal: Cell communication and signaling : CCS

Published: December 16, 2025

Showing 1-12 of 269

Last Updated: 09/26/2026